![Steven Harr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Harr
Grundare på
SANA BIOTECHNOLOGY, INC.
Förmögenhet: 31 M $ per 2026-06-30
Profil
Steven D.
Harr was the founder of JW Therapeutics (Shanghai) Co., Ltd., founded in 2016, serving as Director from 2016 to 2018.
Dr. Harr is the founder of Sana Biotechnology, Inc., founded in 2018, holding the titles of President, Chief Executive Officer & Director starting in 2026.
Dr. Harr is also the founder of JW (Cayman) Therapeutics Co. Ltd...
Current positions include Treasurer & Director at X-Body, Inc., Director at JW Biotechnology (Shanghai) Co. Ltd., Director at Repertoire Immune Medicines, Inc. since 2020, and President at Cobalt Biomedicine, Inc. Former positions include Independent Director at Loxo Oncology, Inc. from 2016 to 2019 and Chief Financial Officer & Head-Development at Juno Therapeutics, Inc. from 2014 to 2018.
Education includes an undergraduate degree from College of the Holy Cross (Massachusetts) in 1993 and a doctorate from The Johns Hopkins University School of Medicine in 1998.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC. 3,46 % | 2026-03-30 | 8 960 751 ( 3,46 % ) | 31 M $ | 2026-06-30 |
Aktiva positioner av Steven Harr
| Företag | Position | Start |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Grundare | 2018-07-13 |
JW Biotechnology (Shanghai) Co. Ltd. | Direktör/Styrelseledamot | - |
X-Body, Inc.
 X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Direktör/Styrelseledamot | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Direktör/Styrelseledamot | 2020-03-01 |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | President | - |
Tidigare kända positioner av Steven Harr
| Företag | Position | Slut |
|---|---|---|
| LOXO ONCOLOGY INC | Direktör/Styrelseledamot | 2019-02-15 |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Grundare | 2018-09-25 |
| JUNO THERAPEUTICS INC | Finansdirektör/CFO | 2018-03-01 |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Verkställande Direktör | 2014-04-01 |
| ░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░ | - |
Steven Harrs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
95
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
